Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective StrategyAnthony R. Mato, Colleen Dorsey, Nicole Lamanna et al.|Clinical Cancer Research|2020Cited by 115
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research RegistryRachel Cusatis, Bronwen E. Shaw, Carlos Litovich et al.|Transplantation and Cellular Therapy|2024Cited by 68